Science Explorer Back to mapMap
Discussion
Researcher · BioInvent (Sweden) · Sweden

Monika Semmrich

Monika Semmrich publishes mostly in Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

ORCID 0009-0007-9833-9772 OpenAlex
World rank
#2,329,488
of 7,710,434 ranked researchers
Rank in Sweden
#30,083
of 71,437
Works
43
Citations
1.3k
Citations per work
30.4
h-index
10
i10-index 10Top 74% in Immunology
Monika Semmrich

What does Monika Semmrich research?

Monika Semmrich's work is mostly in Medicine (35%), Immunology and Microbiology (31%), Biochemistry, Genetics and Molecular Biology (20%).

Life Sciences: 22 works · 51.0% of their workImmunology and Microbiology: 13 works · 30.9% of their workImmunology: 13 works · 30.9% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 20.1% of their workGenetics: 3 works · 7.4% of their workMolecular Biology: 3 works · 7.4% of their workBiotechnology: 2 works · 5.3% of their workHealth Sciences: 15 works · 35.1% of their workMedicine: 15 works · 35.1% of their workOncology: 9 works · 20.2% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 14.9% of their workEverything else: 6 works · 13.9% of their workTHEIR WORKMonika Semmrich43works
Life Sciences51%Health Sciences35%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1330.9%
    2. Biochemistry, Genetics and Molecular Biology920.1%
    1. Medicine1535.1%
  3. Everything else613.9%
  1. 1Immunology31% of their works
  2. 2Oncology20% of their works
  3. 3Radiology, Nuclear Medicine and Imaging15% of their works
  4. 4Molecular Biology7% of their works
  5. 5Genetics7% of their works
  6. 6Biotechnology5% of their works

Research topics

Which keywords describe Monika Semmrich's research?

The keywords of their largest research topics: Cancer Immunotherapy, Dendritic Cells, Immunity, Fc Receptors, Immunotherapy, Therapeutic Antibodies, Tumor Regression and Gene Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Immunotherapy232 topics
  2. Dendritic Cells151 topic
  3. Immunity151 topic
  4. Fc Receptors131 topic
  5. Immunotherapy132 topics
  6. Therapeutic Antibodies131 topic
  7. Tumor Regression132 topics
  8. Gene Therapy112 topics
  9. Immune Checkpoint Blockade91 topic
  10. PD-1 and PD-L191 topic
  11. CAR T Cells81 topic
  12. Chimeric Antigen Receptor81 topic
  13. AAV61 topic
  14. Viral Vectors61 topic
  15. Bacterial Therapy51 topic
  16. Foxp351 topic
  17. TGF-ß51 topic
  18. Tumor Targeting51 topic
  19. NK Cell Recognition41 topic
  20. Natural Killer Cells41 topic

Where does Monika Semmrich work?

Monika Semmrich's main affiliation in the publication record is BioInvent (Sweden), Sweden.

How many publications and citations does Monika Semmrich have?

OpenAlex counts 43 works and 1,306 citations for Monika Semmrich, an h-index of 10, ranking #2,329,488 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Monika Semmrich. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.